A Phase Ib Clinical Study Evaluating the Safety and Efficacy of Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Patients With Advanced Non-small Cell Lung Cancer
Latest Information Update: 09 Jul 2023
At a glance
- Drugs Pyrotinib (Primary) ; Trastuzumab (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 06 Jun 2023 preliminary results presented at the 59th Annual Meeting of the American Society of Clinical Oncology
- 25 Aug 2021 New trial record